Patents by Inventor Yves Fouron

Yves Fouron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9211243
    Abstract: The present application relates to a cosmetic composition comprising at least one ester corresponding to formula (I) below: R1COOR2??(I) in which R1 represents H or a linear or branched hydrocarbon-based radical, and R2 represents a linear or branched hydrocarbon-based radical, with the proviso that: when R2 is a linear hydrocarbon-based radical and R1 is H or a linear hydrocarbon-based radical, then 7?R1+R2?8; and when at least one of R1 and R2 is a branched hydrocarbon-based radical, then 8?R1+R2?10, with the proviso that, when R1 is tert-butyl, then R2 is not isohexyl. This composition can be used as a product for caring for and/or making up keratin materials, in particular the skin, the lips and/or the integuments.
    Type: Grant
    Filed: November 21, 2007
    Date of Patent: December 15, 2015
    Assignee: L'OREAL
    Inventors: Frédéric Auguste, Jean-Yves Fouron
  • Publication number: 20100143273
    Abstract: The present application relates to a cosmetic composition comprising, in a physiologically acceptable medium, at least one aprotic hydrocarbon-based volatile solvent comprising no more than one branch, the volatility of said solvent being such that the amount evaporated in 30 minutes is between 4.1 mg/cm2 and 24 mg/cm2. This composition can be used as a product for caring for and/or making up keratin materials, in particular the skin, the lips and/or the integuments.
    Type: Application
    Filed: November 20, 2007
    Publication date: June 10, 2010
    Inventors: Frédéric Auguste, Jean-Yves Fouron
  • Patent number: 7585847
    Abstract: The invention involves administration of an immunostimulatory nucleic acid alone or in combination with an asthma/allergy medicament for the treatment or prevention of asthma and allergy in subjects. The combination of drugs are administered in synergistic amounts or in various dosages or at various time schedules. The invention also relates to kits and compositions concerning the combination of drugs.
    Type: Grant
    Filed: February 2, 2001
    Date of Patent: September 8, 2009
    Assignee: Coley Pharmaceutical Group, Inc.
    Inventors: Robert L. Bratzler, Deanna M. Petersen, Yves Fouron
  • Publication number: 20080171009
    Abstract: Keratin fibre makeup kit containing at least: a first composition with a surface energy of less than or equal to 30 mN/m, and a second composition with a surface energy such that the difference between its surface energy and that of the first composition is greater than or equal to 5 mN/m, and a viscosity of between 0.001 and 2 Pa·s.
    Type: Application
    Filed: January 4, 2008
    Publication date: July 17, 2008
    Applicant: L'OREAL
    Inventors: Frederic AUGUSTE, Jean-Yves Fouron
  • Publication number: 20080161394
    Abstract: The present application relates to a cosmetic composition comprising at least one carbonic acid ester corresponding to formula (I) below: R1—O—CO—O—R2 ??(I) in which R1 and R2 are identical or different and represent a linear or branched hydrocarbon-based radical, with the proviso that: when R1 and R2 are linear, they each contain from 1 to 6 carbon atoms, with 6?R1+R2?7; and when R1 and/or R2 are branched, they each contain from 1 to 8 carbon atoms, with 6?R1+R2?9. This composition can be used as a product for caring for and/or making up keratin materials, in particular the skin, the lips and/or the integuments.
    Type: Application
    Filed: November 21, 2007
    Publication date: July 3, 2008
    Inventors: Jean-Yves Fouron, Frederic Auguste
  • Publication number: 20080138302
    Abstract: The present application relates to a cosmetic composition comprising at least one ester corresponding to formula (I) below: R1COOR2 ??(I) in which R1 represents H or a linear or branched hydrocarbon-based radical, and R2 represents a linear or branched hydrocarbon-based radical, with the proviso that: when R2 is a linear hydrocarbon-based radical and R1 is H or a linear hydrocarbon-based radical, then 7?R1+R2?8; and when at least one of R1 and R2 is a branched hydrocarbon-based radical, then 8?R1+R2?10, with the proviso that, when R1 is tert-butyl, then R2 is not isohexyl. This composition can be used as a product for caring for and/or making up keratin materials, in particular the skin, the lips and/or the integuments.
    Type: Application
    Filed: November 21, 2007
    Publication date: June 12, 2008
    Inventors: Frederic Auguste, Jean-Yves Fouron
  • Publication number: 20070037767
    Abstract: The invention involves administration of an immunostimulatory nucleic acid alone or in combination with an asthma/allergy medicament for the treatment or prevention of asthma and allergy in subjects. The combination of drugs are administered in synergistic amounts or in various dosages or at various time schedules. The invention also relates to kits and compositions concerning the combination of drugs.
    Type: Application
    Filed: September 22, 2006
    Publication date: February 15, 2007
    Applicant: Coley Pharmaceutical Group, Inc.
    Inventors: Robert Bratzler, Deanna Petersen, Yves Fouron
  • Publication number: 20060154890
    Abstract: The invention involves administration of an immunostimulatory nucleic acid alone or in combination with an asthma/allergy medicament for the treatment or prevention of asthma and allergy in subjects. The combination of drugs are administered in synergistic amounts or in various dosages or at various time schedules. The invention also relates to kits and compositions concerning the combination of drugs.
    Type: Application
    Filed: December 9, 2005
    Publication date: July 13, 2006
    Applicant: Coley Pharmaceutical Group, Inc.
    Inventors: Robert Bratzler, Deanna Petersen, Yves Fouron
  • Publication number: 20040235774
    Abstract: The invention involves administration of an immunostimulatory nucleic acid alone or in combination with an asthma/allergy medicament for the treatment or prevention of asthma and allergy in subjects. The combination of drugs are administered in synergistic amounts or in various dosages or at various time schedules. The invention also relates to kits and compositions concerning the combination of drugs.
    Type: Application
    Filed: April 23, 2004
    Publication date: November 25, 2004
    Inventors: Robert L. Bratzler, Deanna M. Petersen, Yves Fouron
  • Publication number: 20040067902
    Abstract: The invention involves administration of an immunostimulatory nucleic acid alone or in combination with an asthma/allergy medicament for the treatment or prevention of asthma and allergy in subjects. The combination of drugs are administered in synergistic amounts or in various dosages or at various time schedules. The invention also relates to kits and compositions concerning the combination of drugs.
    Type: Application
    Filed: February 2, 2001
    Publication date: April 8, 2004
    Inventors: Robert L. Bratzler, Deanna M. Petersen, Yves Fouron
  • Patent number: 6713056
    Abstract: The present invention relates to combined preparation containing as active substance the following individual components, in the form of a kit-of-parts: monocyte derived cells, particularly cytotoxic macrophages, chemotherapy or immunotherapy drugs, for the simultaneous, separate or sequential use, for the treatment of cancer or infectious diseases.
    Type: Grant
    Filed: November 29, 2000
    Date of Patent: March 30, 2004
    Assignee: I.D.M. Immuno-Designed Molecules
    Inventors: Jacques Bartholeyns, Yves Fouron, Jean-Loup Romet-Lemonne
  • Publication number: 20040018184
    Abstract: The present invention relates to combined preparation containing as active substance the following individual components, in the form of a kit-of-parts:
    Type: Application
    Filed: July 21, 2003
    Publication date: January 29, 2004
    Applicant: I.D.M. IMMUNO-DESIGNED MOLECULES
    Inventors: Jacques Bartholeyns, Yves Fouron, Jean-Loup Romet-Lemonne
  • Patent number: 6616925
    Abstract: The present invention relates to combined preparation containing as active substance the following individual components, in the form of a kit-of-parts: monocyte derived cells, particularly cytotoxic macrophages, chemotherapy or immunotherapy drugs, for the simultaneous, separate or sequential use, for the treatment of cancer or infectious diseases.
    Type: Grant
    Filed: May 19, 1998
    Date of Patent: September 9, 2003
    Assignee: I.D.M. Immuno-Designed Molecules
    Inventors: Jacques Bartholeyns, Yves Fouron, Jean-Loup Romet-Lemonne
  • Publication number: 20030087848
    Abstract: The invention involves administration of an immunostimulatory nucleic acid alone or in combination with an asthma/allergy medicament for the treatment or prevention of asthma and allergy in subjects. The combination of drugs are administered in synergistic amounts or in various dosages or at various time schedules. The invention also relates to kits and compositions concerning the combination of drugs.
    Type: Application
    Filed: February 2, 2001
    Publication date: May 8, 2003
    Inventors: Robert L. Bratzler, Deanna M. Petersen, Yves Fouron
  • Publication number: 20020168347
    Abstract: The invention relates to monocyte derived cells, in a purified form and substantially free of contaminants, presenting antigenic epitopes on their membranes after interiorization and processing of at least an antigen-antibody complex formed between an antigen and an antibody, under appropriate conditions, said epitopes corresponding to proteolytic degradation products of said antigen,
    Type: Application
    Filed: May 18, 1998
    Publication date: November 14, 2002
    Inventors: JACQUES BARTHOLEYNS, YVES FOURON
  • Patent number: 6338839
    Abstract: A transfer-resistant make-up or care composition, comprising: a fatty phase, and a volatile solvent comprising a linear decamethyltetrasiloxane and at least one additional solvent which has an evaporation speed that is greater than the evaporation speed of the linear decamethyltetrasiloxane.
    Type: Grant
    Filed: August 10, 1999
    Date of Patent: January 15, 2002
    Assignee: L'Oreal
    Inventors: Frédéric Auguste, Pascal Arnaud, Jean-Yves Fouron
  • Patent number: 6159375
    Abstract: Filter devices for simultaneously removing leukocytes and viral inactivating agents from whole blood or blood fractions are disclosed. One type of device comprises (1) a housing surrounding (2) activated carbon and (3) a mechanically stable polymeric material which may optionally be modified to attach a ligand for leukocytes. General methods for removing leukocytes and viral inactivating agents from blood and plasma are also disclosed.
    Type: Grant
    Filed: August 9, 1999
    Date of Patent: December 12, 2000
    Assignee: Hemasure, Inc.
    Inventors: Eric Kin-Lam Lee, Yves Fouron, Franco Castino, Charles Melvyn Zepp
  • Patent number: 5935436
    Abstract: Filter devices for simultaneously removing leukocytes and viral inactivating agents from whole blood or blood fractions are disclosed. One type of device comprises (1) a housing surrounding (2) activated carbon and (3) a mechanically stable polymeric material which may optionally be modified to attach a ligand for leukocytes. General methods for removing leukocytes and viral inactivating agents from blood and plasma are also disclosed.
    Type: Grant
    Filed: May 23, 1997
    Date of Patent: August 10, 1999
    Assignee: Hemasure Inc.
    Inventors: Eric Kin-Lam Lee, Yves Fouron, Franco Castino, Charles Melvyn Zepp
  • Patent number: 5817237
    Abstract: Filter devices for simultaneously removing leukocytes and viral inactivating agents from whole blood or blood fractions are disclosed. One type of device comprises (1) a housing surrounding (2) activated carbon and (3) a mechanically stable polymeric material which may optionally be modified to attach a ligand for leukocytes. General methods for removing leukocytes and viral inactivating agents from blood and plasma are also disclosed.
    Type: Grant
    Filed: June 4, 1997
    Date of Patent: October 6, 1998
    Assignee: Hemasure, Inc.
    Inventors: Eric Kin-Lam Lee, Yves Fouron, Franco Castino, Charles Melvyn Zepp
  • Patent number: 5639376
    Abstract: Filter devices for simultaneously removing leukocytes and methylene blue from whole blood or blood fractions are disclosed. One type of device comprises (1) a housing surrounding (2) activated carbon and (3) a mechanically stable polymeric material which may optionally be modified to attach a ligand for leukocytes. General methods for removing leukocytes and methylene blue from blood and plasma are also disclosed.
    Type: Grant
    Filed: November 30, 1994
    Date of Patent: June 17, 1997
    Assignee: HemaSure, Inc.
    Inventors: Eric Kin-Lam Lee, Yves Fouron, Franco Castino, Charles Melvyn Zepp, Abdul R. M. Azad